Balchem Reports Second Quarter 2025 Financial Results

Montvale, NJ, July 31, 2025 – Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal second quarter ended June 30, 2025. For the quarter, the Company reported net sales of $255.5 million, net earnings of $38.3 million, adjusted EBITDA^(a) of $69.2 million, and free cash flow^(a) of $40.7 million.

Second Quarter 2025 Financial Highlights:

• Record net sales of $255.5 million, an increase of $21.4 million, or 1%, compared to the prior year quarter.
• GAAP net earnings were $38.3 million, an increase of 4%, from the prior year quarter.
• Record adjusted EBITDA was $69.2 million, an increase of 2%, from the prior year quarter.
• GAAP earnings per share of $1.17 compared to $0.98 in the prior year quarter and record adjusted earnings per share^(a) of $1.27 compared to $1.09 in the prior year quarter.
• Cash flows from operations were $47.3 million, with free cash flow^(a) of $40.7 million.
• Sales and earnings from operations growth in all three of our reporting segments with record sales and earnings from operations in Human Nutrition and Health and Specialty Products.

Recent Highlights:

• Balchem announced its intent to build a new $36 million state-of-the-art food ingredient and nutraceutical micro-encapsulation manufacturing facility in Orange County, NY. If approved by the county, the facility will more than double Balchem’s capacity for its fast-growing micro-encapsulation technologies.
• In late June 2025, the European Commission announced that it would impose provisional anti-dumping duties of 95.4% to 120.8% on imports into the European Union of choline chloride originating in the People’s Republic of China, effective July 1, 2025

_{(a) See “Non-GAAP Financial Information” for reconciliations of GAAP and non-GAAP financial measures.}

Quarterly Conference Call

A quarterly conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results. Ted Harris, Chairman, President and CEO and Martin Bengtsson, CFO will host the call. Institutional investors, analysts and other members of the financial community are invited to join the live call by dialing 800-715-9871 (toll free USA/Canada), +1-646-307-1963 (USA/International) or 647-932-3411 (Canada/Toronto), five minutes prior to the scheduled start time of the conference call. Investors and the public are invited to listen to the live webcast at https://events.q4inc.com/attendee/126702503. The conference call will be available for replay shortly after the conclusion of the call at https://events.q4inc.com/attendee/126702503 for one year.